CLINICAL TRIALS PROFILE FOR HYDROXOCOBALAMIN
✉ Email this page to a colleague
All Clinical Trials for Hydroxocobalamin
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01147289 ↗ | Efficacy and Safety of Injectable Association of Dexamethasone, Dipyrone and Hydrocobalamin in Lumbar Sciatic Pain | Completed | Eurofarma Laboratorios S.A. | Phase 3 | 2011-02-01 | A phase III, randomized, multicenter, open label clinical trial to evaluate efficacy and safety of the injectable association of dexamethasone, dipyrone, and hydroxocobalamin in lumbar sciatic pain. The study will enroll 140 patients in each arm (280 total). |
NCT01656616 ↗ | Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis | Withdrawn | Maine Medical Center | 2012-08-01 | The costs to a rural emergency medical services (EMS) system of a change from a traditional cyanide antidote kit to a kit containing hydroxocobalamin alone are currently unknown. The purpose of this study is to use current EMS data to calculate the costs to a rural EMS system associated with the adoption of a hydroxocobalamin protocol for the treatment of suspected cyanide exposure. | |
NCT01656616 ↗ | Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis | Withdrawn | MaineHealth | 2012-08-01 | The costs to a rural emergency medical services (EMS) system of a change from a traditional cyanide antidote kit to a kit containing hydroxocobalamin alone are currently unknown. The purpose of this study is to use current EMS data to calculate the costs to a rural EMS system associated with the adoption of a hydroxocobalamin protocol for the treatment of suspected cyanide exposure. | |
NCT02270749 ↗ | Vitamin Deficiencies and Suppletion in Morbid Obesity | Completed | Rijnstate Hospital | Phase 4 | 2014-10-01 | The purpose of this study is to evaluate the most effective treatment for patients who underwent a Roux-en-Y gastric bypass and developed postoperatively a vitamin B12 deficiency. |
NCT03372447 ↗ | Megadose of Hydroxocobalamin for the Treatment of Pernicious Anemia | Completed | Hospital Universitario Dr. Jose E. Gonzalez | Phase 4 | 2017-12-27 | Demonstrate the effectiveness of a single dose of a multivitamin complex for the treatment of megaloblastic anemia |
NCT03446599 ↗ | Hemodynamic Effects of Methylene Blue vs Hydroxocobalamin in Patients at Risk of Vasoplegia During Cardiac Surgery | Withdrawn | Dartmouth-Hitchcock Medical Center | Phase 2 | 2019-11-01 | This is a pilot study to determine the hemodynamic effects when hydroxocobalamin vs methylene blue is administered during cardiopulmonary bypass in patients at risk of vasoplegia by measuring mean arterial pressure (MAP), systemic vascular resistance (SVR) and vasopressor requirement. |
NCT03735316 ↗ | Vitamin B12a Vasoplegic Syndrome | Recruiting | Mayo Clinic | Phase 2 | 2019-04-25 | The study team will evaluate the medication Hydroxocobalamin (B12a) for treatment of low blood pressure after cardiac surgery. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Hydroxocobalamin
Condition Name
Clinical Trial Locations for Hydroxocobalamin
Trials by Country
Clinical Trial Progress for Hydroxocobalamin
Clinical Trial Phase
Clinical Trial Sponsors for Hydroxocobalamin
Sponsor Name